ClearPoint Neuro Inc. (CLPT)
NASDAQ (CM) NASDAQ (CM) Primary Summary
ClearPoint Neuro (CLPT) Surges 26.0%: Is This an Indication of Further Gains?
ClearPoint Neuro (CLPT) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Compared to Estimates, ClearPoint Neuro (CLPT) Q1 Earnings: A Look at Key Metrics
Although the revenue and EPS for ClearPoint Neuro (CLPT) give a sense of how its business performed in the quarter ended March 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
ClearPoint Neuro, Inc. (CLPT) Reports Q1 Loss, Lags Revenue Estimates
ClearPoint Neuro, Inc. (CLPT) came out with a quarterly loss of $0.32 per share versus the Zacks Consensus Estimate of a loss of $0.28. This compares to a loss of $0.22 per share a year ago.
ClearPoint Neuro Inc. Investors
| Name | Quantity | Cost | Value | Profit ($) | Gain (%) |
|---|---|---|---|---|---|
 Joseph Castro Nuveen LLC | 62,502 | $744,902.3 | $982,531.44 | $237,629.14 | 31.9% |
| RS Richard Slavik Newbridge Financial Services Group Inc. | 1 | $15.38 | $15.79 | $0.41 | 2.67% |
 Brian Baylis Bell Investment Advisors Inc. | 104 | $706.16 | $1,642.16 | $936 | 132.55% |
| CAL CoreCap Advisors LLC CoreCap Advisors LLC | 8,054 | $54,767.2 | $126,608.88 | $71,841.68 | 131.18% |
| SP Samantha Pierangeli City State Bank | 850 | $6,769 | $12,765.81 | $5,996.81 | 88.59% |
ClearPoint Neuro Inc. (CLPT) FAQ
What is the stock price today?
On which exchange is it traded?
What is its stock symbol?
Does it pay dividends? What is the current yield?
What is its market cap?
Has ClearPoint Neuro Inc. ever had a stock split?
ClearPoint Neuro Inc. Profile
| Health Care Equipment & Supplies Industry | Healthcare Sector | Joseph Michael Burnett CEO | NASDAQ (CM) Exchange | 18507C103 CUSIP |
| US Country | 172 Employees | - Last Dividend | 27 Jul 2016 Last Split | 12 Feb 2020 IPO Date |
Overview
ClearPoint Neuro, Inc. is a prominent medical device company primarily operating in the United States, with a focus on developing and commercializing innovative platforms designed for performing minimally invasive surgical procedures in the brain. These procedures are guided by magnetic resonance imaging (MRI), ensuring precision and safety. The company, originally known as MRI Interventions, Inc., underwent a name change to ClearPoint Neuro, Inc. in February 2020, marking a new chapter in its commitment to advancing neurological interventions. Incorporated in 1998 and based in Solana Beach, California, ClearPoint Neuro has established various strategic license and collaboration agreements with notable entities such as Clinical Laserthermia Systems AB, Koninklijke Philips N.V., UCB Biopharma SRL, and the University of California and San Francisco. Additionally, it has entered into a development and license agreement with NE Scientific, LLC, further expanding its research and development capabilities in pursuit of innovative neurological treatment options.
Products and Services
The ClearPoint Neuro, Inc. portfolio includes the ClearPoint system, among other pioneering technologies focused on enhancing the efficacy and safety of neurosurgical interventions:
- ClearPoint System: This integrated system represents a significant advancement in the field of neurosurgery. It is specifically designed for the precise insertion of deep brain stimulation electrodes, biopsy needles, laser catheters, and the infusion of pharmaceuticals directly into the brain. The ClearPoint system facilitates these procedures under real-time MRI guidance, enabling surgeons to perform interventions with improved accuracy and reduced risk to the patient. This system underscores ClearPoint Neuro's commitment to improving the quality of life for patients undergoing neurological treatments by providing a minimally invasive alternative to traditional surgical approaches.
